- Representing a major generic pharmaceutical company asserting antitrust and breach of contract claims against the branded manufacturer for steps taken to block generic entry.
- Trial counsel for a Fortune 500 global communications company in a standard essential patent licensing dispute.
- Represented multiple Fortune 500 food and beverage manufacturers and distributers in national product labeling class actions.
- Obtained regulatory approval for LHC Group Inc.’s $5.4 billion acquisition by UnitedHealth Group after counselling client through Second Request by Federal Trade Commission.
- Represented a cybersecurity technology company in arbitration asserting breach of contract claims against a reseller and defended against counterclaims worth hundreds of millions of dollars with favorable results for the client.
- Counsel for a major generic pharmaceutical company in a consumer class action alleging antitrust violations based on nondisclosure of essential patents to the U.S. Pharmacopeial Convention. (M.D.Tenn.).
- Defended a major pharmaceutical company in a Department of Justice investigation into alleged price fixing and market allocation in the generic pharmaceutical industry.
- Trial counsel defending a major insurance company in a certified RICO class action lawsuit where the claimed damages were approximately $9 billion; the case settled for less than 3 percent of the damages after a jury was empanelled. (S.D.Ill.).
Senior Associate,
- Phone: +1 404 881 7256
- Email: troy.stram@alston.com
Both plaintiffs and defendants rely on Troy’s litigation experience to provide creative solutions for their high-stakes commercial disputes.